Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2009

View Archived Issues

Propiverine shows good combination of efficacy and tolerability in neurogenic detrusor overactivity

NB-001 deemed safe and efficacious in patients with recurrent herpes labialis

Results from the SATORI study with tocilizumab in RA patients disclosed

Prolonged-release ropinirole improves symptom control in Parkinson's patients

Servier claims novel napthalene derivatives that inhibit melatonin receptors

Memantine beneficial in patients with Parkinson's disease dementia or dementia with Lewy bodies

Chiesi describes new PDE4 inhibitors useful for asthma and other respiratory disorders

Boehringer Ingelheim reports quinazolinedione chymase inhibitors for cardiovascular disorders

New compounds for bacterial infections under development at AstraZeneca

Taisho and Meiji Seika present novel antibacterial agents

New cytochrome P450 inhibitors for HIV infections claimed by Gilead

Emergent BioSolutions commences phase I/II anthrax immune globulin trial

Last patient visit completed in Kamada's phase II inhaled AAT bronchiectasis study

Allos Therapeutics' pralatrexate granted European orphan drug designation for bladder cancer

Synta initiates phase I/II clinical trial of STA-9090 in hematologic malignancies

Tepnel shareholders approve acquisition by Gen-Probe

Biotec completes patient inclusion in its first phase III diabetic ulcer study

Compugen's Relaxin receptor peptide ligand shows efficacy in pulmonary fibrosis animal model

MannKind submits NDA for Afresa for the treatment of diabetes

Melior Discovery advances MLR-1023 into clinical studies

MiddleBrook launches Moxatag (once-daily amoxicillin)

Prometheus Laboratories receives New York State approval for IBS diagnostic Prometheus

CytRx's arimoclomol improves stroke recovery in preclinical trial in rats

Cordis initiates NEVO II clinical trial comparing Nevo and Xience V coronary stents

Synairgen presents update on phase I SG004 clinical trial of IFN-beta in asthmatic volunteers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...